Premium
Inhibition of the Class II HMG–CoA reductase of Pseudomonas mevalonii
Author(s) -
Hedl Matija,
Rodwell Victor W.
Publication year - 2004
Publication title -
protein science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.353
H-Index - 175
eISSN - 1469-896X
pISSN - 0961-8368
DOI - 10.1110/ps.03597504
Subject(s) - hmg coa reductase , reductase , enzyme , mevalonate pathway , biochemistry , lovastatin , stereochemistry , coenzyme a , chemistry , hydroxymethylglutaryl coa reductase , statin , ligand (biochemistry) , biology , cholesterol , receptor
There are two structural classes of HMG–CoA reductase, the third enzyme of the mevalonate pathway of isopentenyl diphosphate biosynthesis—the Class I enzymes of eukaryotes and the Class II enzymes of certain eubacteria. Structural requirements for ligand binding to the Class II HMG–CoA reductase of Pseudomonas mevalonii were investigated. For conversion of mevalonate to HMG–CoA the −CH 3 , −OH, and −CH 2 COO − groups on carbon 3 of mevalonate were essential for ligand recognition. The statin drug Lovastatin inhibited both the conversion of HMG–CoA to mevalonate and the reverse of this reaction. Inhibition was competitive with respect to HMG–CoA or mevalonate and noncompetitive with respect to NADH or NAD + . K i values were millimolar. The over 10 4 ‐fold difference in statin K i values that distinguishes the two classes of HMG–CoA reductase may result from differences in the specific contacts between the statin and residues present in the Class I enzymes but lacking in a Class II HMG–CoA reductase.